2Lautier D, Canitor Y, Deeley RG, et al. Multidrug resistance mediated by the multidrug resistance protein (MRP) gene [J]. Biochem Pharm, 1996, 52 (7) :967--977.
3Takebayashi Y, Akiyama S, Natsugoe S, et al. The expression of multidrug resistance protein in human gastrointestinal tract carcinomas [J]. Cancer, 1998,82(4):661--666.
4Endo K, Maehara Y, Kusumoto T, et al. Expression of multidrug resistance-associated protein and chemosensitivity in human gastric cancer [J]. Int J Cancer, 1996,68 (3) : 372 -- 377.
5Izquierdo MA, Scheffer GL, Fleus MJ, et al. Major vault protein LRP-related multidrug resistance [J].Eur J Cancer, 1996,32(6):979-994.
6Kitazommo M, Sumizawa T, Takebayashi Y, et al.Multidrug resistance and the lung resistance-related protein in human colon carcinoma SW-120 cell [J]. J Natl Cancer Inst, 1999,91 (20) : 1647-- 1653.
7Hehlmann R, Hochhaus A, Baccarani M. Chronic myeloid leukaemia [ J]. Lancet,2007,370:342 - 350.
8Haiman C,Setiawan V,Xia L,et al. A variant in the cytochrome p450 oxidoreductase gene is associated with breast cancer risk in African Americans [ J ]. Cancer Res, 2007, 67:3565 - 3568.
9Yuille M,Condie A, Hudson C, et al. Relationship between glutathione S-transferase M1, T1, and P1 polymorphisms and chronic lymphocytic leukemia [ J ]. Blood, 2002,99 : 4216 -4218.
10Hung R, Moore L, Boffetta P, et al. Family history and the risk of kidney cancer: a multicenter case-control study in Central Europe [ J ]. Cancer Epidemiol Biomarkers Prey, 2007,16 : 1287 - 1290.
